DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Jan 2015 to December 2015 Name: Adam DeVore Title: Instructor in Medicine Address: 2400 Pratt Street, Durham, NC 27705 Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. Lectures for CME) for >$5K/1% Abbott Laboratories Abiomed Achillion Air Products, PLC Alcon Aldagen, Alexion Allergan, Alnylam Altarum Alpharma, Amerigroup Corp. Amgen, Amylin, Anadys Anesiva, page 1 of 12; 10/01/2012
Lectures for CME) for >$5K/1% Angel Medical Systems, Aptus Endosystems, ArgiNox Array Biopharma Astellas Pharma US Astra Hassle AstraZeneca Atritech Aventis Baxter Bayer US (Bayer AG/Bayer in Japan subsidiaries) Bayer HealthCare (formerly Berlex Labs) Bayer (JP) Bayer Yakuhin, Ltd. BG Medicine BioCryst Biogen Idec Bioheart 2 of 12;10/01/2010
Lectures for CME) for >$5K/1% Biomarker Factory Boehringer Ingelheim Boehringer Manheim Boston Scientific Bristol Myers Squibb Canyon Cappella Cardinal CardioDx, Cardioxyl Celsion Centocor Ceremed, Cerexa, Charles River Laboratories Chase Medical Cochrane Conatus, Conor Medsystems, Cordis 3 of 12;10/01/2010
Lectures for CME) for >$5K/1% Covidien Critical Diagnostics CSL Limited Cubist CV Therapeutics, Cytokinetics, Daiichi Sankyo Dendreon DURECT Edwards Lifesciences Elesvier Eli Lilly & EnteroMedics, EOCI Pharmacomm Ltd. Ethicon Endo- Surgery Ethicon, Evalve, Exoxemis F2G, Ltd. Genentech 4 of 12;10/01/2010
Lectures for CME) for >$5K/1% General Electric Healthcare Genomic Health Genzyme Gilead Sciences, Glaxo SmithKline (GSK) GlobeImmune Gloucester GlycoMimetics, Guidant Heartscape Technologies, Helsinn Healthcare Hoffmann-La Roche Hospira, Human Genome Sciences, ico Therapeutics Idera, Ikaria INC Inimex 5 of 12;10/01/2010
Lectures for CME) for >$5K/1% Innocoll Inspire Intarcia Therapeutics, Ischemix, Iverson Genetic Diagnostics, Janssen Products Johnson & Johnson Johnson & Johnson & Development KAI Kaiser Permanente Life Masters Supported Self Care, Lilly Luitpold, M-3 Information 6 of 12;10/01/2010
Lectures for CME) for >$5K/1% MAQUET Cardiovascular LLC (formerly Boston Scientific Cardiac & Vascular) MedImmune Medscape, LLC Medtronic Diabetes Medtronic Vascular, (formerly Medtronic AVE) Medtronic, Merck & Co. Merck Group Merck Sharp & Dohme I.A. Millennium, (formerly COR Therapeutics) Miracor Medical Systems Momenta NeoPharm, Neuron 7 of 12;10/01/2010
Lectures for CME) for >$5K/1% NeuroScience, NovaCardia, Novartis AG Group Novartis Novartis Vaccines and Diagnostics, (formerly Chiron Corp) Oncura OrbusNeich Orexigen Therapeutics, Ortho-McNeil- Janssen, Ortho-McNeil- Janssen Scientific Affairs, L.L.C. OSI Eyetech OSI Osiris Therapeutics, Otsuka America Palo Alto CSCC 8 of 12;10/01/2010
Lectures for CME) for >$5K/1% PENTAX Medical Peregrine Pfizer Pharmacyclics Pharmassest, Pharmos Phyxius Pharms LLC Pluristem Therapeutics, Portola POZEN Proctor & Gamble ProStrakan, Proventys Regado Biosciences, Revalesio Corp Roche Diagnostic Corp. Roche Group Roche Molecular Systems, RTI Health Solutions Sanofi-Aventis 9 of 12;10/01/2010
Lectures for CME) for >$5K/1% Sanofi Pasteur, (formerly Aventis Pasteur) Santaris Pharma A/S Schering-Plough Scios, SCYNEXIS Shire PLC Siemens Solvay, SRI International Summit Sunovion, Takeda Co. Tengion Tethys Bioscience The EMMES The Medicines Theravance Theregen, 10 of 12;10/01/2010
Lectures for CME) for >$5K/1% Three Rivers Transition, UCB Pharma United Therapeutics United Healthcare Veridex Vertex, Viacor, Inc Westat Wyeth XTL Biopharmaceuticals ZymoGenetics, Thoratec American Heart Association Column Explanations: (1) Funding is provided for my effort in research grants or contracts for multi-center projects in which I serve as either the Chairman, Co-Chairman, Executive or Steering Committee member or I am involved as a DCRI faculty leader for specific aspects in a project. A check in this column denotes that I am involved in such a research contract. Payments for the work performed for these contracts are made to the. A portion of my salary as a faculty member, representative of % effort on the project, is supported by these funds. 11 of 12;10/01/2010
research grant company supports the expenses associated with projects in the DUHS that are under my direction. (3) I provide educational activities or deliver occasional lectures that generate revenue company. All revenues from these activities are paid to the. None of it is taken for personal income. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. (4) I receive personal income outside of my salary for consulting or other services (Including CME) company. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. (5) I receive personal income outside of my salary for consulting or other non-cme services company. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. personally receive royalties in excess of $5,000 per year company. (7) I, or an immediate member of my family, have equity (with shareholder voting privileges) in this company of either > $5,000 or > 1%. 12 of 12;10/01/2010